/Companies

アドリアカイム株式会社

1 known investors

Find your way into アドリアカイム株式会社

Sign up to see every warm intro you have to アドリアカイム株式会社

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the アドリアカイム株式会社 team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

AdriaKaim develops medical devices for cardiac disease, focusing on a vagus nerve stimulation device based on its own technology intended to prevent chronic heart failure following acute myocardial infarction. The company is a spinout venture founded to commercialize acute myocardial infarction treatment devices developed with support from Japan's National Cerebral and Cardiovascular Center.

Investors · 1

Frequently asked questions

What does アドリアカイム株式会社 do?
AdriaKaim develops medical devices for cardiac disease, focusing on a vagus nerve stimulation device based on its own technology intended to prevent chronic heart failure following acute myocardial infarction. The company is a spinout venture founded to commercialize acute myocardial infarction treatment devices developed with support from Japan's National Cerebral and Cardiovascular Center.
Who are アドリアカイム株式会社's investors?
アドリアカイム株式会社's investors include UTokyo Innovation Platform Co. Ltd..